Nanologica
Manufactures nanoporous silica for cost-effective purification of peptide drugs for pharma.
NICA | ST
Overview
Corporate Details
- ISIN(s):
- SE0005454873 (+2 more)
- LEI:
- 54930017L41C7P87LP22
- Country:
- Sweden
- Address:
- Forskargatan 20 G, 151 36 Södertälje
- Website:
- https://nanologica.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Nanologica is a life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. The company specializes in nanoporous silica particles for preparative chromatography. Its flagship product, NLAB Saga®, is a high-performance silica medium engineered for the large-scale purification of peptide drugs, such as insulin and GLP-1 analogues used in treating diabetes and obesity. NLAB Saga® offers superior mechanical and chemical stability, which increases purification efficiency and product lifetime, thereby enhancing productivity and reducing costs for drug producers. The company's mission is to improve global access to cost-effective medicines through its advanced purification technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-01 09:55 |
Regulatory News Service
Nanologica AB (publ) Enters the Insulin Market in China
|
English | 47.5 KB | ||
| 2025-10-01 09:55 |
Regulatory News Service
Nanologica AB (publ) tar sig in på insulinmarknaden i Kina
|
Swedish | 47.7 KB | ||
| 2025-07-10 08:10 |
Quarterly Report
|
Swedish | 828.6 KB | ||
| 2025-07-10 08:10 |
Quarterly Report
|
English | 856.3 KB | ||
| 2025-06-30 11:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Nanologica AB (publ)
|
Swedish | 44.5 KB | ||
| 2025-06-30 11:00 |
Share Issue/Capital Change
Number of Shares and Votes in Nanologica AB (publ)
|
English | 43.9 KB | ||
| 2025-06-13 10:34 |
M&A Activity
UTTALANDE FRÅN STYRELSEN I NANOLOGICA AB (PUBL) MED ANLEDNING AV BUDPLIKTSERBJU…
|
Swedish | 51.9 KB | ||
| 2025-06-13 10:34 |
M&A Activity
STATEMENT FROM THE BOARD OF DIRECTORS OF NANOLOGICA AB (PUBL) REGARDING THE MAN…
|
English | 50.7 KB | ||
| 2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) TAR ORDER OM CA 1,3 MSEK FRÅN NY KUND I USA
|
Swedish | 48.9 KB | ||
| 2025-06-12 08:14 |
Regulatory News Service
NANOLOGICA AB (PUBL) RECEIVES ORDER OF APPX. SEK 1.3 MILLION FROM NEW CUSTOMER …
|
English | 48.6 KB | ||
| 2025-05-23 16:41 |
Share Issue/Capital Change
Nanologica AB (publ) meddelar utfall av inlösen av teckningsoptioner av serie T…
|
Swedish | 41.2 KB | ||
| 2025-05-23 16:41 |
Declaration of Voting Results & Voting Rights Announcements
Nanologica AB (publ) Announces the Outcome of the Exercise of Warrants of Serie…
|
English | 40.5 KB | ||
| 2025-05-23 07:36 |
M&A Activity
Kommentar från styrelsen i Nanologica AB (publ) angående budpliktsbud från Fler…
|
Swedish | 48.3 KB | ||
| 2025-05-23 07:36 |
Legal Proceedings Report
Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from…
|
English | 48.3 KB | ||
| 2025-05-22 14:54 |
Post-Annual General Meeting Information
Bulletin from the AGM 2025 Nanologica AB (publ)
|
English | 48.0 KB |
Automate Your Workflow. Get a real-time feed of all Nanologica filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Nanologica via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-25 | Thomas Eldered | Other | Buy | 666,570 | 661,170.78 SEK |
| 2024-10-03 | Mattias Bengtsson | Other | Other | 114,361 | 1,029,249.00 SEK |
| 2024-10-03 | Gisela Sitbon | Other | Other | 333,336 | 750,006.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 917,641 | 2,294,102.50 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 917,641 | 2,064,692.25 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 447,628 | 1,119,070.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 447,628 | 1,007,163.00 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 351,631 | 879,077.50 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 351,631 | 791,169.75 SEK |
| 2024-10-01 | Alexandra Blomberg Montgomery | Other | Other | 72,507 | 181,267.50 SEK |
